BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34958986)

  • 1. StarD13 negatively regulates invadopodia formation and invasion in high-grade serous (HGS) ovarian adenocarcinoma cells by inhibiting Cdc42.
    Abdellatef S; Fakhoury I; Haddad MA; Jaafar L; Maalouf H; Hanna S; Khalil B; El Masri Z; Hodgson L; El-Sibai M
    Eur J Cell Biol; 2022 Jan; 101(1):151197. PubMed ID: 34958986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation.
    Al Haddad M; El-Rif R; Hanna S; Jaafar L; Dennaoui R; Abdellatef S; Miskolci V; Cox D; Hodgson L; El-Sibai M
    Cell Commun Signal; 2020 Sep; 18(1):144. PubMed ID: 32900380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. StarD13 differentially regulates migration and invasion in prostate cancer cells.
    Jaafar L; Fakhoury I; Saab S; El-Hajjar L; Abou-Kheir W; El-Sibai M
    Hum Cell; 2021 Mar; 34(2):607-623. PubMed ID: 33420961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of StarD13 on colorectal cancer proliferation, motility and invasion.
    Nasrallah A; Saykali B; Al Dimassi S; Khoury N; Hanna S; El-Sibai M
    Oncol Rep; 2014 Jan; 31(1):505-15. PubMed ID: 24253896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion.
    Hanna S; Khalil B; Nasrallah A; Saykali BA; Sobh R; Nasser S; El-Sibai M
    Int J Oncol; 2014 May; 44(5):1499-511. PubMed ID: 24627003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARHGAP17 regulates the spatiotemporal activity of Cdc42 at invadopodia.
    Kreider-Letterman G; Castillo A; Mahlandt EK; Goedhart J; Rabino A; Goicoechea S; Garcia-Mata R
    J Cell Biol; 2023 Feb; 222(2):. PubMed ID: 36571786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intersection of TKS5 and FGD1/CDC42 signaling cascades directs the formation of invadopodia.
    Zagryazhskaya-Masson A; Monteiro P; Macé AS; Castagnino A; Ferrari R; Infante E; Duperray-Susini A; Dingli F; Lanyi A; Loew D; Génot E; Chavrier P
    J Cell Biol; 2020 Sep; 219(9):. PubMed ID: 32673397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. StarD13: a potential star target for tumor therapeutics.
    Jaafar L; Chamseddine Z; El-Sibai M
    Hum Cell; 2020 Jul; 33(3):437-443. PubMed ID: 32274657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13.
    Chen L; Hu W; Li G; Guo Y; Wan Z; Yu J
    Cell Mol Biol Lett; 2019; 24():20. PubMed ID: 30899277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts.
    Goicoechea SM; García-Mata R; Staub J; Valdivia A; Sharek L; McCulloch CG; Hwang RF; Urrutia R; Yeh JJ; Kim HJ; Otey CA
    Oncogene; 2014 Mar; 33(10):1265-73. PubMed ID: 23524582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FilGAP, a GAP for Rac1, down-regulates invadopodia formation in breast cancer cells.
    Saito K; Ozawa S; Chiba Y; Takahashi R; Ogomori R; Mukai K; Taguchi T; Hatakeyama H; Ohta Y
    Cell Struct Funct; 2023 Sep; 48(2):161-174. PubMed ID: 37482421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Cdc42 and Rac small G proteins in invadopodia formation of RPMI7951 cells.
    Nakahara H; Otani T; Sasaki T; Miura Y; Takai Y; Kogo M
    Genes Cells; 2003 Dec; 8(12):1019-27. PubMed ID: 14750956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene.
    Li Y; Zhang H; Gong H; Yuan Y; Li Y; Wang C; Li W; Zhang Z; Liu M; Liu H; Chen J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):141. PubMed ID: 29986736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TC10 regulates breast cancer invasion and metastasis by controlling membrane type-1 matrix metalloproteinase at invadopodia.
    Hülsemann M; Sanchez C; Verkhusha PV; Des Marais V; Mao SPH; Donnelly SK; Segall JE; Hodgson L
    Commun Biol; 2021 Sep; 4(1):1091. PubMed ID: 34531530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal fibroblasts facilitate cancer cell invasion by a novel invadopodia-independent matrix degradation process.
    Cao H; Eppinga RD; Razidlo GL; Krueger EW; Chen J; Qiang L; McNiven MA
    Oncogene; 2016 Mar; 35(9):1099-1110. PubMed ID: 25982272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MT4-MMP promotes invadopodia formation and cell motility in FaDu head and neck cancer cells.
    Yan X; Cao N; Chen Y; Lan HY; Cha JH; Yang WH; Yang MH
    Biochem Biophys Res Commun; 2020 Feb; 522(4):1009-1014. PubMed ID: 31813546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-9-5p Facilitates Lung Adenocarcinoma Cell Malignant Progression via Targeting STARD13.
    Lu Y; Zheng W; Rao X; Du Y; Xue J
    Biochem Genet; 2022 Dec; 60(6):1865-1880. PubMed ID: 35119587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma.
    El-Sitt S; Khalil BD; Hanna S; El-Sabban M; Fakhreddine N; El-Sibai M
    Oncol Rep; 2012 Aug; 28(2):511-8. PubMed ID: 22614672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.
    Sharma A; Mendonca J; Ying J; Kim HS; Verdone JE; Zarif JC; Carducci M; Hammers H; Pienta KJ; Kachhap S
    Mol Oncol; 2017 Jun; 11(6):655-669. PubMed ID: 28371345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIP4 targeted to recruit GTP-Cdc42 involving in invadopodia formation via NF-κB signaling pathway promotes invasion and metastasis of CRC.
    Hu Z; Zhu J; Ma Y; Long T; Gao L; Zhong Y; Wang X; Li Z
    Mol Ther Oncolytics; 2022 Mar; 24():873-886. PubMed ID: 35317515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.